Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Rhamnazin, a novel inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy.

Authors
Type
Published Article
Journal
Biochemical and Biophysical Research Communications
0006-291X
Publication Date
Volume
458
Issue
4
Pages
913–919
Identifiers
DOI: 10.1016/j.bbrc.2015.02.059
PMID: 25704088
Source
Medline
Keywords
  • Angiogenesis
  • Breast Cancer
  • Rhamnazin
  • Vegfr2

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments